Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Adachi, M.
space
  arrow  Ishii, H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido

right arrow Masayuki Adachi, MD; Hidetsugu Saito, MD, PhD; Hisashi Kobayashi, MD; Yoshinori Horie, MD, PhD; Shinzo Kato, MD, PhD; Masahiro Yoshioka, MD, PhD; and Hiromasa Ishii, MD, PhD

16 September 2003 | Volume 139 Issue 6 | Pages 488-492

Background: The Chinese herbal dietary supplements Chaso and Onshido are marketed for weight loss in Japan. The safety of these weight loss aids is unknown.

Objective: To describe patients who developed liver injury while taking Chaso or Onshido.

Design: Case series.

Setting: Keio University Hospital, Tokyo, Japan, and other hospitals in Japan.

Patients: 6 patients who took Chaso and 6 patients who took Onshido before presenting with liver injury.

Measurements: Pathologic, clinical, and laboratory evaluations and chemical analysis of the herbal weight loss aids.

Results: All 12 patients developed acute liver injury characterized by a marked increase in serum liver chemistry values (mean alanine aminotransferase level, 1978 U/L [range, 283 to 4074 U/L]) after ingesting these products. Two patients developed fulminant hepatic failure: 1 patient required liver transplantation, and the other patient died. N-nitroso-fenfluramine, a variant of the appetite-depressant drug fenfluramine, was present in these products.

Conclusions: The use of the weight loss aids Chaso and Onshido may be associated with acute liver injury. N-nitroso-fenfluramine is a possible hepatotoxic ingredient.


Editors' Notes
space

Context

  • Herbal weight loss aids are marketed as quick, safe fixes for obesity.

Contribution

  • This report describes 12 Japanese patients who developed liver injury while taking the herbal weight loss aids Chaso or Onshido. Chemical analysis of these products showed N-nitroso-fenfluramine, the active compound in a weight loss drug that the U.S. Food and Drug Administration withdrew from the U.S. market.

Cautions

  • This case series cannot tell us how frequently herbal weight loss aids lead to liver injury, nor can it prove that N-nitroso-fenfluramine is the toxic agent.

Conclusion

  • This report suggests that herbal weight loss aids are unsafe in some people.

–The Editors

 

Author and Article Information
space

From Keio University School of Medicine and Minami Tama Hospital, Tokyo, Japan.

Acknowledgments: The authors thank Drs. Naoko Hanawa, Teikyo University Itabashi Hospital (patient 2); Makiko Kinoshita, Wakayama Coop Hospital (patient 3); Michiko Negishi, Jikei Medical College Hospital (patient 5); Yshihiro Yamada, Mitsukoshi Corporation Clinic (patient 6); Hideaki Miura, Social Insurance Central Hospital (patient 8); Shingo Maeyama, Kaizuka City Hospital (patient 9); and Hiroshi Nakagawara, Tobu-Chiiki Hospital (patient 12), for patient information. The authors also thank Drs. Kanji Wakabayashi, Misa Mizumori, Toshiaki Inamura, Atsushi Sakuraba, Tomoyasu Nishimura, Mihoko Tsuji, and Tomoko Yamashita, Keio University, and Hideo Eno, The Ministry of Health, Labour and Welfare in Japan, for their cooperation.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Hiromasa Ishii, MD, PhD, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Current Author Addresses: Drs. Adachi, Saito, Kobayashi, Horie, Kato, and Ishii: Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Dr. Yoshioka: Minami Tama Hospital, 3-10-1 Santa-cho, Hachioji-shi, Tokyo, 192-0831, Japan.

Author Contributions: Conception and design: M. Adachi, H. Saito, H. Ishii.

Analysis and interpretation of the data: M. Adachi, H. Saito, H. Kobayashi, Y. Horie, S. Kato, M. Yoshioka, H. Ishii.

Drafting of the article: M. Adachi, H. Saito, H. Ishii.

Critical revision of the article for important intellectual content: M. Adachi, H. Saito, Y. Horie, S. Kato, H. Ishii.

Final approval of the article: M. Adachi, H. Saito, M. Yoshioka, H. Ishii.

Provision of study materials or patients: M. Adachi, H. Saito, H. Kobayashi, M. Yoshioka, H. Ishii.

Statistical expertise: M. Adachi, H. Saito, H. Ishii.

Obtaining of funding: H. Ishii.

Administrative, technical, or logistic support: M. Adachi, H. Saito, H. Kobayashi, S. Kato, H. Ishii.

Collection and assembly of data: M. Adachi, H. Saito, H. Kobayashi, S. Kato, M. Yoshioka, H. Ishii.


Related articles in Annals:

Summaries for Patients
Liver Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido
Annals 2003 139: I-47. [Full Text]  



This article has been cited by other articles:


Home page
British Journal of Diabetes & Vascular DiseaseHome page
A. H Barnett
Review: Pharmacotherapy as part of a weight management programme: a UK perspective
The British Journal of Diabetes & Vascular Disease, November 1, 2007; 7(6): 268 - 277.
[Abstract] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2003 by the American College of Physicians.